FDA OKs DexCom's continuous glucose technology
This article was originally published in Clinica
Executive Summary
DexCom saw its shares jump last week, after the US FDA approved for sale its continuous glucose monitor for helping diabetics more conveniently and effectively manage their blood sugar levels.